Finance
At this page you will find information about our finance strategy and vision, key financial figures (Global and Europe) as well as stock information.
Finance highlights - Europe
Our marketing and sales efforts in Europe are focused on cardiovascular, metabolic disease and the infectious disease products.
Financial key figures - Tokyo
We continue to create innovative pharmaceuticals and aim to expand our business focusing on pharmaceuticals to major areas of the world by 2015.
